| Bladder Cancer | BLCA | BCG vaccine | TRAIL | TNFSF10 | NA | 29133939 | Details |  |  |  |  |
| Bladder Cancer | BLCA | Atezolizumab | PD-L1 | CD274 | clinical trial phase 2 | 29133939 | Details | | | | |
| Bladder Cancer | BLCA | Anti-PD-L1 | CD8+ TIL | NA | mouse model | 27471612 | Details | | | | |
| Bladder Cancer | BLCA | Anti-PD-L1 | granzyme B | GZMB | mouse model | 27471612 | Details | | | | |
| Bladder Cancer | BLCA | Anti-PD-L1 | IL-7 | IL7 | mouse model | 27471612 | Details | | | | |
| Bladder Cancer | BLCA | Anti-PD-L1 | IL-15 | IL15 | mouse model | 27471612 | Details | | | | |
| Bladder Cancer | BLCA | Anti-PD-L1 | IL-12 | IL12A | mouse model | 27471612 | Details | | | | |
| Bladder Cancer | BLCA | Anti-PD-L1 | IL-2 | IL2 | mouse model | 27471612 | Details | | | | |
| Bladder Cancer | BLCA | Anti-PD-L1 | IFN-γ | IFNG | mouse model | 27471612 | Details | | | | |
| Bladder Cancer | BLCA | Anti-PD-L1 | TNF-α | TNF | mouse model | 27471612 | Details | | | | |
| Bladder Cancer | BLCA | vesigenurtacel-L(HS-410) | TIL | NA | clinical trial phase 1/2 | 29133939 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD8+ T cells | Naive CD8+ T cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD8+ T cells | Effector CD8+ memory T (Tem) cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD8+ T cells | Exhausted CD8+ T cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD8+ T cells | CD8+ T cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD8+ T cells | CD8+ cytotoxic T cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD11c+ DCs | CD16+ dendritic cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD11c+ DCs | Conventional dendritic cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD11c+ DCs | Myeloid conventional dendritic cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD11c+ DCs | Dendritic cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD11c+ DCs | Plasmacytoid dendritic cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD11c+ DCs | Monocyte derived dendritic cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD11c+ DCs | Myeloid dendritic cell | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | MHC-II | NA | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD80 | CD80 | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | anti-PD1 Ab | CD86 | CD86 | Mouse model | 29337311 | Details | | | | |
| Bladder Cancer | BLCA | DNA vaccine | CD8+ T cells | Naive CD8+ T cell | Mouse model | 29246320 | Details | | | | |
| Bladder Cancer | BLCA | DNA vaccine | CD8+ T cells | Effector CD8+ memory T (Tem) cell | Mouse model | 29246320 | Details | | | | |
| Bladder Cancer | BLCA | DNA vaccine | CD8+ T cells | Exhausted CD8+ T cell | Mouse model | 29246320 | Details | | | | |
| Bladder Cancer | BLCA | DNA vaccine | CD8+ T cells | CD8+ T cell | Mouse model | 29246320 | Details | | | | |
| Bladder Cancer | BLCA | DNA vaccine | CD8+ T cells | CD8+ cytotoxic T cell | Mouse model | 29246320 | Details | | | | |
| Bladder Cancer | BLCA | DNA vaccine | IFN-γ | IFNG | Mouse model | 29246320 | Details | | | | |